NEW YORK LIFE INVESTMENT MANAGEMENT LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK LIFE INVESTMENT MANAGEMENT LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$435,985
-31.0%
9,480
-13.7%
0.01%
-28.6%
Q2 2023$631,595
+33.9%
10,990
-12.6%
0.01%
+40.0%
Q1 2023$471,788
+6.8%
12,581
-20.2%
0.01%0.0%
Q4 2022$441,623
+12.1%
15,761
+12.4%
0.01%0.0%
Q3 2022$394,000
-12.8%
14,020
+7.9%
0.01%0.0%
Q2 2022$452,00012,9900.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders